HPLC determination and pharmacokinetic studies of salvianolic acid B in rat plasma after oral administration of Radix Salviae Miltiorrhizae extract

被引:42
作者
Zhang, JL
Yu, HL
Sheng, YX
Li, L
Ye, M
Guo, D
机构
[1] Peking Univ, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
[2] Peking Univ, Modern Res Ctr Tradit Chinese Med, Beijing 100083, Peoples R China
关键词
salvianolic acid B; Radix Salviae Miltiorhizae; high-performance liquid chromatography; pharmacokinetic studies;
D O I
10.1002/bmc.408
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A precise and reproducible HPLC method has been established and validated for determination of salvianolic acid B (SaIB) in rat plasma after oral administration of Radix Salviae Miltiorrhizae extract. Liquid-liquid extraction was adopted for the sample preparation. Separation was accomplished on a C, column with a linear gradient elution consisting of acetonitrile and aqueous phosphoric acid. Ultraviolet detection was at 280 run. The method was validated over the concentration range 10.8-259.4 mug/mL using 1 mL of plasma. The assay was linear over this concentration range with a coefficient of variation less than 7%. The extraction recovery of SaIB was within the range 71-83% with RSD 11%. The mean recovery of the internal standard was 84% (n = 6) with RSD of 5.6%. This method is suitable to determine SalB in plasma and to investigate the pharmacokinelics of SalB. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 9 条
  • [1] DU GH, 2000, BASIC MED SCI CLIN, V2, P394
  • [2] Li L.-N., 1997, J. Chinese Pharmacetical Sci, V6, P57
  • [3] LING HY, 1999, NATURAL PRODUCT RES, V11, P75
  • [4] Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats
    Tang, MK
    Ren, DC
    Zhang, JT
    Du, GH
    [J]. PHYTOMEDICINE, 2002, 9 (05) : 405 - 409
  • [5] WANG J, 1999, CHINESE PHARMACOL B, V15, P237
  • [6] Wang NX, 1999, CHINA OCEAN ENG, V13, P197
  • [7] Zhao FQ, 1997, BIOL PHARM BULL, V20, P285, DOI 10.1248/bpb.20.285
  • [8] ZHOU CX, 1999, J CHINA PHARM U, V80, P411
  • [9] Zhuang YanLi, 1999, Acta Pharmaceutica Sinica, V34, P613